November 02, 2015
Wilson Therapeutics Appoints Anders Martin-Löf as Chief Financial Officer
Media
October 30, 2015
NORDIC NANOVECTOR TO HOST CAPITAL MARKETS DAY IN OSLO ON 17 NOVEMBER 2015
October 27, 2015
NORDIC NANOVECTOR: POSTER PRESENTATION OF PRECLINICAL STUDIES COMPARING BETALUTIN® WITH Lu-177 CHIMERIC ANTI-CD37 ANTIBODY RADIONUCLIDE CONJUGATE
October 21, 2015
NORDIC NANOVECTOR: RESULTS FOR THE THIRD QUARTER AND FIRST NINE MONTHS OF 2015
October 20, 2015
WILSON THERAPEUTICS APPOINTS ANDREW KAY AS CHAIRMAN
October 16, 2015
Strongbridge Biopharma plc Announces Pricing of Its Initial U.S. Public Offering
October 15, 2015
Nordic Nanovector adapts clinical development plan for Betalutin® in Follicular Lymphoma
October 08, 2015
Nexstim Plc Supports 7th International Symposium on Navigated Brain Stimulation in Neurosurgery
September 30, 2015
Appointment of Mr. Andrew Kay to HealthCap Senior Advisor
September 30, 2015
Appointment of Mr. Andrew Kay to HealthCap Senior Advisor
